Everest Medicines Market Cap

Everest Medicines has a market cap or net worth of 16.04 billion as of December 5, 2025. Its market cap has increased by 43.33% in one year.

Market Cap

16.04B

Enterprise Value

15.11B

Revenue

932.82M

Ranking

n/a

PE Ratio

n/a

Stock Price

45.40

Market Cap Chart

Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 16.04B, a decrease of -22.29%. That is a compound annual growth rate of -4.77%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	16.04B	2.86%
Dec 31, 2024	15.59B	132.87%
Dec 29, 2023	6.70B	24.60%
Dec 30, 2022	5.37B	-47.96%
Dec 31, 2021	10.33B	-47.98%
Dec 31, 2020	19.85B	-3.81%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	284.43B
Hansoh Pharmaceutical Group Company	243.25B
JD Health International	196.41B
Innovent Biologics	157.33B
WuXi Biologics	126.66B
Sino Biopharmaceutical	120.67B
Akeso	110.17B
Sichuan Kelun-Biotech Biopharmaceutical	102.18B

Market Cap Rankings